KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $35.6 million.

  • Charles River Laboratories International's Capital Expenditures fell 811.19% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.8 million, marking a year-over-year decrease of 1266.83%. This contributed to the annual value of $233.0 million for FY2024, which is 2686.14% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Capital Expenditures is $35.6 million, which was down 811.19% from $35.3 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Capital Expenditures registered a high of $106.9 million during Q2 2023, and its lowest value of $28.0 million during Q1 2021.
  • Its 5-year average for Capital Expenditures is $65.0 million, with a median of $67.4 million in 2023.
  • Per our database at Business Quant, Charles River Laboratories International's Capital Expenditures skyrocketed by 18706.39% in 2022 and then crashed by 4140.07% in 2024.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Capital Expenditures stood at $98.8 million in 2021, then fell by 9.87% to $89.0 million in 2022, then dropped by 12.02% to $78.3 million in 2023, then decreased by 3.46% to $75.6 million in 2024, then plummeted by 52.95% to $35.6 million in 2025.
  • Its Capital Expenditures was $35.6 million in Q3 2025, compared to $35.3 million in Q2 2025 and $59.3 million in Q1 2025.